|
PTPDC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.73827999999654E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.203160E-03 |
| Normal-vs-Stage2 |
2.369900E-02 |
| Normal-vs-Stage3 |
4.144800E-01 |
| Normal-vs-Stage4 |
4.645000E-01 |
| Stage1-vs-Stage2 |
4.420600E-01 |
| Stage1-vs-Stage3 |
3.229000E-01 |
| Stage1-vs-Stage4 |
5.801400E-01 |
| Stage2-vs-Stage3 |
2.146000E-01 |
| Stage2-vs-Stage4 |
3.423000E-01 |
| Stage3-vs-Stage4 |
9.292000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.18079999999765E-05 |
| Normal-vs-AfricanAmerican |
4.496800E-03 |
| Normal-vs-Asian |
6.820000E-01 |
| Caucasian-vs-AfricanAmerican |
7.521000E-01 |
| Caucasian-vs-Asian |
4.767400E-01 |
| AfricanAmerican-vs-Asian |
4.932400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.841180E-04 |
| Normal-vs-Female |
1.215020E-04 |
| Male-vs-Female |
1.268450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.876100E-02 |
| Normal-vs-Extreme_Weight |
3.023900E-02 |
| Normal-vs-Obese |
2.384500E-03 |
| Normal-vs-Extreme_Obese |
8.724400E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.711200E-01 |
| Normal_Weight-vs-Obese |
2.445400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.796800E-01 |
| Extreme_Weight-vs-Obese |
1.750620E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.863600E-01 |
| Obese-vs-Extreme_Obese |
9.416800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.390420E-01 |
| Normal-vs-Age(41-60Yrs) |
3.0511999999927E-06 |
| Normal-vs-Age(61-80Yrs) |
1.599580E-03 |
| Normal-vs-Age(81-100Yrs) |
5.023600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.769800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.769400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.338200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.191020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.461570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.357400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.17970000049306E-07 |
| Normal-VS-Type2 PRCC |
3.443400E-01 |
| Normal-VS-KIRP CIMP |
6.792400E-01 |
| Normal-VS-Unclassified PRCC |
1.206120E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.183390E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.529600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.542800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.522600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.054500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.335600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.846000E-02 |
| Normal-vs-N1 |
3.936000E-01 |
| Normal-vs-N2 |
7.057000E-01 |
| N0-vs-N1 |
8.185000E-01 |
| N0-vs-N2 |
3.435800E-01 |
| N1-vs-N2 |
6.255000E-01 |
|
|
